trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Adenomyosis D062788 1 associated lipids
Neoplasm Micrometastasis D061206 1 associated lipids
Visceral Pain D059265 1 associated lipids
Inflammatory Breast Neoplasms D058922 2 associated lipids
Capsule Opacification D058442 1 associated lipids
Intervertebral Disc Degeneration D055959 1 associated lipids
Small Cell Lung Carcinoma D055752 2 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Classical Lissencephalies and Subcortical Band Heterotopias D054221 1 associated lipids
Atherosclerosis D050197 85 associated lipids
Genomic Instability D042822 7 associated lipids
Mastocytoma D034801 3 associated lipids
Gestational Trophoblastic Disease D031901 1 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Spinocerebellar Ataxias D020754 4 associated lipids
Stroke D020521 32 associated lipids
Myopathy, Central Core D020512 1 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Roseolovirus Infections D019349 1 associated lipids
Porcine Reproductive and Respiratory Syndrome D019318 4 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Thyroid Hormone Resistance Syndrome D018382 1 associated lipids
Neuroendocrine Tumors D018358 4 associated lipids
Rhabdoid Tumor D018335 1 associated lipids
Cystadenoma, Serous D018293 1 associated lipids
Cystadenocarcinoma, Serous D018284 2 associated lipids
Cystadenocarcinoma, Mucinous D018282 1 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Papillary, Follicular D018265 1 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Rhabdomyosarcoma, Alveolar D018232 2 associated lipids
Fibromatosis, Aggressive D018222 2 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Leukemia, Myelomonocytic, Acute D015479 6 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Reperfusion Injury D015427 65 associated lipids
Supratentorial Neoplasms D015173 1 associated lipids
Uveal Neoplasms D014604 3 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Translocation, Genetic D014178 20 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Osteosarcoma D012516 50 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Rubinstein-Taybi Syndrome D012415 1 associated lipids
Retinoblastoma D012175 12 associated lipids
Radiation Injuries D011832 14 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Progeria D011371 3 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Osteomalacia D010018 5 associated lipids
Neuroblastoma D009447 66 associated lipids
Nerve Degeneration D009410 53 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Neoplasms D009369 13 associated lipids
Nasopharyngeal Neoplasms D009303 4 associated lipids
Nasal Polyps D009298 26 associated lipids
Opioid-Related Disorders D009293 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Intellectual Disability D008607 13 associated lipids
Melanoma D008545 69 associated lipids
Medulloblastoma D008527 22 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lupus Vulgaris D008177 1 associated lipids
Lung Neoplasms D008175 171 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Leukemia D007938 74 associated lipids
Leishmaniasis D007896 19 associated lipids
Keloid D007627 12 associated lipids
Chromosome Inversion D007446 1 associated lipids
Inflammation D007249 119 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Hypesthesia D006987 1 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Hypertension D006973 115 associated lipids
Hypersensitivity D006967 22 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Hosseinkhani M et al. Trichostatin A induces myocardial differentiation of monkey ES cells. 2007 Biochem. Biophys. Res. Commun. pmid:17368572
Dangond F and Gullans SR Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate. 1998 Biochem. Biophys. Res. Commun. pmid:9647779
Tomita K et al. The effect of oxidative stress on histone acetylation and IL-8 release. 2003 Biochem. Biophys. Res. Commun. pmid:12565901
Ailenberg M and Silverman M Differential effects of trichostatin A on gelatinase A expression in 3T3 fibroblasts and HT-1080 fibrosarcoma cells: implications for use of TSA in cancer therapy. 2003 Biochem. Biophys. Res. Commun. pmid:12604329
Takamatsu G et al. Tescalcin is a potential target of class I histone deacetylase inhibitors in neurons. 2017 Biochem. Biophys. Res. Commun. pmid:27939885
Bai L and Merchant JL ATM phosphorylates ZBP-89 at Ser202 to potentiate p21waf1 induction by butyrate. 2007 Biochem. Biophys. Res. Commun. pmid:17560543
Higashi T et al. Histone H2A mobility is regulated by its tails and acetylation of core histone tails. 2007 Biochem. Biophys. Res. Commun. pmid:17445770
Gan Y et al. Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells. 2006 Biochem. Biophys. Res. Commun. pmid:16338217
Kishigami S et al. Significant improvement of mouse cloning technique by treatment with trichostatin A after somatic nuclear transfer. 2006 Biochem. Biophys. Res. Commun. pmid:16356478
Aquea F et al. Chemical inhibition of the histone acetyltransferase activity in Arabidopsis thaliana. 2017 Biochem. Biophys. Res. Commun. pmid:27993678
Takechi S et al. Chicken HDAC2 down-regulates IgM light chain gene promoter activity. 2002 Biochem. Biophys. Res. Commun. pmid:12437980
Hagiwara H et al. Histone deacetylase inhibitor trichostatin A enhances myogenesis by coordinating muscle regulatory factors and myogenic repressors. 2011 Biochem. Biophys. Res. Commun. pmid:22019851
Ailenberg M and Silverman M Trichostatin A-histone deacetylase inhibitor with clinical therapeutic potential-is also a selective and potent inhibitor of gelatinase A expression. 2002 Biochem. Biophys. Res. Commun. pmid:12379227
Park KS et al. Histone modification-mediated Lhx2 gene expression. 2012 Biochem. Biophys. Res. Commun. pmid:23036195
Sakata R et al. Trichostatin A activates the osteopontin gene promoter through AP1 site. 2004 Biochem. Biophys. Res. Commun. pmid:14985105
Noh EJ et al. An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner. 2009 Biochem. Biophys. Res. Commun. pmid:19038231
Ishimaru N et al. Differential epigenetic regulation of BDNF and NT-3 genes by trichostatin A and 5-aza-2'-deoxycytidine in Neuro-2a cells. 2010 Biochem. Biophys. Res. Commun. pmid:20188708
Steiner E et al. SP-transcription factors are involved in basal MVP promoter activity and its stimulation by HDAC inhibitors. 2004 Biochem. Biophys. Res. Commun. pmid:15047174
Rossi M et al. Caspase cleavage of Itch in chronic lymphocytic leukemia cells. 2009 Biochem. Biophys. Res. Commun. pmid:19073138
Noh EJ and Lee JS Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition. 2003 Biochem. Biophys. Res. Commun. pmid:14521905
Heo H et al. Suppression of caspase-11 expression by histone deacetylase inhibitors. 2009 Biochem. Biophys. Res. Commun. pmid:19013432
Togi S et al. HDAC3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A. 2009 Biochem. Biophys. Res. Commun. pmid:19121623
Nan X et al. Potent stimulation of gene expression by histone deacetylase inhibitors on transiently transfected DNA. 2004 Biochem. Biophys. Res. Commun. pmid:15465025
Sugita K et al. A novel compound, depudecin, induces production of transformation to the flat phenotype of NIH3T3 cells transformed by ras-oncogene. 1992 Biochem. Biophys. Res. Commun. pmid:1731795
Li H and Wu X Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells. 2004 Biochem. Biophys. Res. Commun. pmid:15474507
Harada Y et al. A hematopoietic-specific transmembrane protein, Art-1, is possibly regulated by AML1. 2001 Biochem. Biophys. Res. Commun. pmid:11396961
Nagaraja SS et al. Effect of Trichostatin A on radiation induced epithelial-mesenchymal transition in A549 cells. 2017 Biochem. Biophys. Res. Commun. pmid:28993195
Choi HS et al. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. 2002 Biochem. Biophys. Res. Commun. pmid:12200149
Yamamura A et al. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. 2013 Biochem. Biophys. Res. Commun. pmid:24134849
Shindo N et al. The ESC-E(Z) complex participates in the hedgehog signaling pathway. 2005 Biochem. Biophys. Res. Commun. pmid:15652519
Choi S et al. Histone deacetylases inhibitor trichostatin A modulates the extracellular release of APE1/Ref-1. 2013 Biochem. Biophys. Res. Commun. pmid:23665318
Maehara K et al. Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene. 2002 Biochem. Biophys. Res. Commun. pmid:12083788
Wang XQ et al. Histone deacetylase inhibition results in decreased macrophage CD9 expression. 2002 Biochem. Biophys. Res. Commun. pmid:12056820
Carambula SF et al. Repression of induced apoptosis in the 2-cell bovine embryo involves DNA methylation and histone deacetylation. 2009 Biochem. Biophys. Res. Commun. pmid:19665989
Hejnar J et al. Demethylation of host-cell DNA at the site of avian retrovirus integration. 2003 Biochem. Biophys. Res. Commun. pmid:14623319
Ghosh AK et al. MBP-1 physically associates with histone deacetylase for transcriptional repression. 1999 Biochem. Biophys. Res. Commun. pmid:10403782
Herr MJ et al. Tetraspanin CD9 modulates human lymphoma cellular proliferation via histone deacetylase activity. 2014 Biochem. Biophys. Res. Commun. pmid:24747564
Sun P et al. Effect of trichostatin A on Burkitt's lymphoma cells: Inhibition of EPS8 activity through Phospho-Erk1/2 pathway. 2018 Biochem. Biophys. Res. Commun. pmid:29462617
Park KK et al. Modulation of Sp1-dependent transcription by a cis-acting E2F element in dhfr promoter. 2003 Biochem. Biophys. Res. Commun. pmid:12788094
Park PH et al. Acetylation of histone H3 at lysine 9 by ethanol in rat hepatocytes. 2003 Biochem. Biophys. Res. Commun. pmid:12804592
Liu J and Li Y Trichostatin A and Tamoxifen inhibit breast cancer cell growth by miR-204 and ERα reducing AKT/mTOR pathway. 2015 Biochem. Biophys. Res. Commun. pmid:26436206
Oshima M et al. Molecular mechanism of transcriptional repression of AhR repressor involving ANKRA2, HDAC4, and HDAC5. 2007 Biochem. Biophys. Res. Commun. pmid:17949687
Choi JH et al. TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116. 2010 Biochem. Biophys. Res. Commun. pmid:19914212
Iacobazzi V et al. Epigenetic mechanisms and Sp1 regulate mitochondrial citrate carrier gene expression. 2008 Biochem. Biophys. Res. Commun. pmid:18706393
Kuusisto E et al. Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. 2001 Biochem. Biophys. Res. Commun. pmid:11162503
Shi H et al. Synergistic induction of miR-126 by hypoxia and HDAC inhibitors in cardiac myocytes. 2013 Biochem. Biophys. Res. Commun. pmid:23201405
Liu J et al. Trichostatin A suppresses lung adenocarcinoma development in Grg1 overexpressing transgenic mice. 2015 Biochem. Biophys. Res. Commun. pmid:26086099
Gan Y et al. Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells. 2008 Biochem. Biophys. Res. Commun. pmid:17996726
Zhao Y et al. Histone acetylation regulates both transcription initiation and elongation of hsp22 gene in Drosophila. 2005 Biochem. Biophys. Res. Commun. pmid:15607742
Hashii M et al. Up-regulation of ras-GAP genes is reversed by a MEK inhibitor and doxorubicin in v-Ki-ras-transformed NIH/3T3 fibroblasts. 2007 Biochem. Biophys. Res. Commun. pmid:17367762